AVS Granted Innovation Award at ISET
AVS received the 2025 Innovation Award at the International Symposium on Endovascular Therapy (ISET), a premier annual event focused on advancements in endovascular techniques and technologies.
Category: News
AVS Brings New Approach to Lithotripsy: Vanguards of Health Care
In a Vanguards of Health Care podcast episode, AVS CEO, Mark Toland sits down with BI analyst Matt Henriksson for an in-depth interview to talk about how the Pulse IVL System is differentiated from the current technology in the market to make it more flexible and durable. He also highlights its initial first-in human results,… Read more »
Pulse IVL with Angie Volk & Sean Gilligan of AVS
Angie Volk, VP of Business Development at AVS, and Sean Gilligan, COO at AVS, recently sat down with Kyle Kruse and Richard Meiklejohn on The Medtech Impact Podcast to discuss AVS’ mission and how the Pulse IVL System is designed to safely and effectively treat calcified arterial disease. Listen to the episode
Cardio Conversations: AVS Talks about Starting a Company in a Pandemic, Cracking Peripheral Plaques and More
Robert Chisena, Ph.D., our CTO and Co-Founder, recently chatted with Reed Miller on the latest edition of the Cardio Conversations, a MedTech Insight podcast, to share his thoughts on our interventional technology, how AVS got its start, where we’re headed in 2024, and more.
AVS’ PIVL™ System in growing PAD market; Details on Medtech’s new digital playbook
AVS Chief Operating Officer, Sean Gilligan, recently sat down with Tom Salemi on the DeviceTalks podcast to discuss AVS’ approach to intravascular lithotripsy and the latest clinical results for the PULSE IVL System. Sean also shared insights from his career and competition in the changing landscape of the PAD market.
Economic Downturn Can Still Spell Success for Medical Devices
Medical device makers navigating today’s economic climate have more hurdles to jump than in the post-Covid investment boom of 2021, and the tighter market demands a purposeful approach from those of us looking to bring new technology to market. Health technology investors have taken a more selective approach1 in the healthcare space in 2023. That… Read more »
Medical Devices Are Evolving Toward Specialized Solutions
Medical devices have existed in some form for centuries, resulting in thousands of innovative implementations over the years. Throughout history, medical devices have addressed a wide array of disease states – often, one device has purpose across different disease states. Devices fall into categories including single use devices, implantables, imaging equipment, medical supplies, software and… Read more »
How has Venture Interest in Medical Devices Evolved?
Our very own Sean Gilligan was recently interviewed by Health Professional Radio to discuss how PIVL works, its applications, and the need for such treatments. Sean also provided an overview of his role here at AVS and shared some thoughts on best practices for R&D at medical device companies. To listen to the full interview… Read more »
Pulsatile Intravascular Lithotripsy: A Novel Mechanism for Peripheral Artery Calcium Fragmentation and Luminal Expansion
“The primary objective of intravascular lithotripsy is to shatter calcium. Based on the histological findings from our early cadaveric studies, Amplitude Vascular Systems‘ pulsatile intravascular lithotripsy (PIVL) mechanism is not only capable of shattering calcium, but it also generates substantial luminal gain using the same method.” Jon George MD, MBA, ReVascMed.
Endovascular Today: AVS Begins POWER PAD I Trial of Pulse IVL Therapy
AVS announced the initiation of enrollment, successful treatment, and positive 30-day follow up data in the POWER PAD I clinical trial.